Open Access

An isothermal DNA amplification method for detection of Onchocerca volvulus infection in skin biopsies

  • Ole Lagatie1Email author,
  • Michelle Merino1,
  • Linda Batsa Debrah2,
  • Alexander Y. Debrah3 and
  • Lieven J. Stuyver1
Parasites & Vectors20169:624

https://doi.org/10.1186/s13071-016-1913-7

Received: 1 August 2016

Accepted: 24 November 2016

Published: 1 December 2016

Abstract

Background

Diagnostic procedures for the diagnosis of infection with the nematode parasite Onchocerca volvulus are currently based on the microscopic detection of microfilariae in skin biopsies. Alternative approaches based on amplification of parasitic DNA in these skin biopsies are currently being explored. Mostly this is based on the detection of the O-150 repeat sequence using PCR based techniques.

Methods

An isothermal, loop-mediated amplification method has been designed using the mitochondrial O. volvulus cox1 gene as a target.

Results

Analysis of dilution series of synthetic DNA containing the targeted sequence show a non-linear dose-response curve, as is usually the case for isothermal amplification methods. Evaluation of cross-reactivity with the heterologous sequence from the closely related parasites Wuchereria bancrofti, Loa loa and Brugia malayi demonstrated strong specificity, as none of these sequences was amplified. The assay however amplified both O. volvulus and O. ochengi DNA, but with a different melting point that can be used to discriminate between the species. Evaluation of this assay in a set of skin snip biopsies collected in an endemic area in Ghana showed a high correlation with O-150 qPCR and also demonstrated a similar sensitivity. Compared to qPCR, LAMP had a sensitivity of 88.2% and a specificity of 99.2%.

Conclusions

We have developed a sensitive and specific loop-mediated amplification method for detection of O. volvulus DNA in skin biopsies that is capable of providing results within 30 min.

Keywords

Onchocerca volvulus River blindness Onchocerciasis Skin biopsy DNA cox1 LAMP Isothermal Diagnostic

Background

Onchocerciasis, infection with the filarial nematode Onchocerca volvulus is a neglected tropical disease which is best known as river blindness [1, 2]. In Africa at least 120 million people are at risk of infection. The last comprehensive survey conducted in 2008 indicated that 26 million people were infected with O. volvulus, of which 265,000 individuals were blind and 746,000 were visually impaired. In addition, approximately four million people suffer from onchodermatitis with severe itching [3]. Presently, treatment is based on microfilaricidal agents, such as ivermectin (Mectizan, Merck), as no approved macrofilaricide drugs or vaccines are available. Since microfilaricides only affect the larval stage of O. volvulus with little or no impact on the adult worm, annual or bi-annual treatments for several years are required [4, 5]. Since the start of these mass drug administration programs (MDA) in 1987, ivermectin has been used to treat hundreds of millions of people with a resultant reduction in both visual impairment and symptomatic onchodermatitis [6].

Evaluation of MDA programs, and ultimately also guidance to stop them, is based mainly on monitoring of infection levels in human populations, as well as in its vector, the blackfly of the genus Simulium. Besides clinical examination by palpation of nodules formed by adult worms (macrofilariae), diagnostic tools for detection of O. volvulus infection involves finding microfilariae (mf) in small, superficial skin biopsy samples (skin snips) using microscopy [7]. The latter can be a challenge, especially when larval densities are low, which is often the case during or the first months after treatment with ivermectin. The sensitivity of this test has been further increased by using polymerase chain reaction based detection of the Onchocerca specific O-150 repeat sequence [811].

Several efforts have been undertaken to identify novel biomarkers that offer a less-invasive, specific and sensitive marker for infection with O. volvulus [12]. The most advanced of these tests, is the rapid-format test for the detection of IgG4 antibodies to the parasitic antigen Ov-16, which is predominantly useful in a surveillance setting [1318]. Another approach that has shown promise is the use of metabolome analysis of serum or urine samples from infected individuals, which has led to the identification of urinary N-acetyltyramine-O,β-glucuronide (NATOG) as a unique biomarker for O. volvulus infection [1921]. More recent work has focused on the detection of parasitic microRNAs in the blood of infected individuals, but the low levels of these biomarkers may pose a real challenge to be useful as a diagnostic marker [2224].

Isothermal amplification provides a simple process that rapidly and efficiently accumulates nucleic acids at constant temperature [25]. In contrast to PCR-based amplification, no temperature cycles are required, which facilitates its integration into microsystems or portable devices. One of the most frequently used isothermal amplification technologies is the loop mediated isothermal amplification (LAMP), which is based on two primer sets that recognized six different sites on the target DNA and an optional third set of primers, so-called loop primers to accelerate the reaction [26, 27]. LAMP offers advantages over other molecular diagnostic methods because it is simple, rapid and highly specific. This technology has been evaluated for the diagnosis of the filarial parasites Brugia malayi [28], Wuchereria bancrofti [29] and Loa loa [3032]. Also for Onchocerca volvulus, a LAMP assay has been developed for surveillance of parasite transmission in the blackfly [33].

In the present study, we report the design of a LAMP assay that targets the mitochondrial encoded O. volvulus cox1 gene. This work provides evidence of the high sensitivity of this assay, and the close concordance with qPCR based detection of O. volvulus DNA.

Methods

Study samples

Skin biopsy samples were collected as part of a field study in Ghana. This study was undertaken in an Onchocerciasis-endemic community located in Adansi South District along the Pra River basins in the Ashanti Region of Ghana. Physical examinations were performed to identify those subjects having palpable nodules. Most subjects were participating in MDA programs with ivermectin. An overview of the patient demographics is provided in Table 1. From each participant two skin biopsies were taken, one from the right and one from the left hip. Immediately after sampling, biopsies were transferred individually into a single round bottom well of a 96-well plate, submerged in saline solution and after overnight incubation at room temperature each biopsy was examined microscopically and the emerged microfilariae of O. volvulus counted. [34]. Thereafter the two biopsies collected from each participant were weighed and transferred individually to microcentrifuge tubes and stored in liquid nitrogen.
Table 1

Characteristics of study populations used in this study

Characteristic

Group

Nodule-positive

Endemic controls

No. of subjects

99

51

Age, median (min-max)

47 (21–85)

35 (18–81)

Gender, n (%)

 Male

53 (54)

26 (51)

 Female

46 (46)

25 (49)

No. of nodules, median (min-max)

1 (1–5)

0

mf status, n (%)

 0 mf/mg

89 (90)

51 (100)

 0–5 mf/mg

9 (9)

0 (0)

 5–10 mf/mg

1 (1)

0 (0)

No. of IVM rounds, median (min-max)

2 (0–10)

0 (0–1)

Time since last treatment

 Not treated

16 (16)

34 (67)

  < 20 months

68 (69)

5 (10)

  > 20 months

15 (15)

12 (24)

Ov16 status, n (%)

 Positive

68 (69)

26 (51)

 Negative

31 (31)

25 (49)

Abbreviations: mf microfilaria, Ov16 O. volvulus antigen with molecular weight of 16 kDa

Extraction of genomic DNA from skin biopsies

Genomic DNA was extracted from each skin biopsy using the OMEGA E.Z.N.A. tissue DNA kit (Norcross, GA, USA), according to the manufacturer’s instructions. DNA was eluted in 200 μl elution buffer. The quantity and quality of extracted DNA was assessed with a NanoDrop Spectrophotometer (ND-1000, Thermo Scientific, Waltham, MA, USA) and DNA was stored at -20 °C before analysis [34]. Extracted DNA concentrations ranged from 0.2 ng/μl to 134 ng/μl. Extracts were diluted in nuclease free water to a concentration of 10 ng/μl, except for those samples which already had a lower concentration, which were used undiluted. In order to confirm that DNA in the extracts was intact and could be amplified, qPCR targeting the human beta-actin gene was performed on 10 ng of template DNA. This was done using the PrimeTime actb qPCR assay, according to the manufacturer’s instructions (Integrated DNA Technologies, Leuven, Belgium). The primers and probe included in the assay were Fwd Primer 5'-CAC GGC TAG CTG TG-3', Rev Primer 5'-ATC GTT CGT TGA GCG ATT AGC AG-3', Probe 5'-6-FAM-GTG GCT CCA TCT TAG CCC TAG T-IBFQ-3' (Iowa Black® FQ), with internal quencher ZEN. Four of the 150 extracts (including 1 mf positive sample) were excluded for further analysis as they did not meet the acceptance criteria described in the statistical analysis below (see Additional file 1: Figure S1).

Quantitative real-time PCR assay for detecting O-150 DNA

A TaqMan qPCR assay based on a previously published method (see [35]) was used to quantify O. volvulus O-150 DNA. The primers and probe included OvFWD 5'-TGT GGA AAT TCA CCT AAA TAT G-3', OvREV 5'-AAT AAC TGA TGA CCT ATG ACC-3', OvProbe 5'-6-FAM-TAG GAC CCA ATT CGA ATG TAT GTA CCC-IBFQ-3' (Iowa Black® FQ), with internal quencher ZEN (Integrated DNA Technologies, Leuven, Belgium). Taqman Universal Master Mix without UNG (Applied Biosystems, P/N 4440040) and nuclease free water were used with all reactions with the following concentrations and volumes: 1 μl of 10 μM OvFWD, 1 μl of 10 μM OvREV, 2.5 μl of 10 μM OvProbe, 10 μl of 2× Master Mix, 5 μl of template DNA from extracted skin biopsies, or 2 μl of linearized Ov-150 positive control plasmid at a concentration of 100 to 106 copies/μl (Integrated DNA Technologies, Leuven, Belgium), and nuclease-free water was added up to a final volume of 20 μl. Reactions were performed in duplicate on a Roche Lightcycler 480 instrument with the following conditions: 95 °C 10 min (95 °C 15 s, 49 °C 15 s, 60 °C 30 s) × 45 cycles. The second derivate method was used to calculate Cq values and samples were considered positive for Ov-150 DNA if Cq (quantification cycle) values were greater than 36.15 (corresponding to 2 log copies/reaction) in both duplicates. The calibration curve (0.3 to 6.3 log copies/reaction) of the O-150 qPCR assay is given by the formula y = -3.57x + 43.29 (Additional file 2: Figure S2).

Loop-mediated isothermal amplification primer design

The complete mitochondrial genome sequence of O. volvulus (NC_001861.1) was retrieved from the NCBI database. LAMP primers targeting O. volvulus mitochondrial DNA were designed using LAMP Designer V1.13 (OptiGene, Horsham, UK). Two sets of primers comprising two outer (F3 and B3), and two inner (FIP and BIP) were selected. FIP contained F1c (complementary to F1), and the F2 sequence. BIP contained the B1c sequence (complementary to B1) and the B2 sequence. Additional loop primers, forward loop primer (LoopF) and backward loop primer (LoopB) were included in the reaction. BLAST analysis [36] of the fragment located between the two outer primers indicated the target gene was cox1.

Loop-mediated isothermal amplification assay

LAMP reactions were performed using the primers designed as described above. LAMP reactions were performed in a final volume of 25 μl. Reaction mixtures contained 12 μl Isothermal Mastermix (OptiGene, Horsham, UK), 0.5 μl of each F3 and B3 primer (10 μM), 2 μl of each FIP and BIP primer (20 μM), 1 μl of each LoopF and LoopB (10 μM), 5 μl of template DNA from extracted skin biopsies, or 5 μl of specific gBlocks (O. volvulus cox1, O. ochengi cox1, W. bancrofti cox1, L. loa cox1 or B. malayi cox1) at a concentration of 100 to 106 copies/μl (Integrated DNA Technologies, Leuven, Belgium), and nuclease-free water was added up to a final volume of 25 μl. The mixture was incubated at 65 °C for 45 min, with fluorescent detection every 30 s on a Roche Lightcycler 480 instrument. At the end of the incubation period, T m determination was performed by increasing the temperature to 95 °C with 5 fluorescence acquisitions per °C. The threshold method, using an arbitrarily selected threshold of 10 RFU, was used to calculate Ct values. Time to LAMP was calculated by dividing the obtained Ct values by 2 (one cycle corresponds to 30 s). The detection limit of LAMP was determined to be 2 log copies/reaction as at this concentration a positive signal was reproducibly obtained in the assay. Based on the calibration curves obtained with the synthetic DNA and the higher variation observed in Time to LAMP at low concentrations (2 log copies/reaction), a cut-off of 30 min was defined. Samples were considered positive if average Time to LAMP < 30 min.

Statistical analysis

Results of human Actin qPCR were subjected to statistical analysis in order to identify samples with poor extraction and/or qPCR efficiency. Average Cq value and standard deviation of all samples was calculated and possible outliers were identified as samples with Cq value > average + 2 standard deviations, SD. In case outliers were detected, samples were not included for further analysis. For comparison of T m values in different groups, a two-tailed unpaired t-test with 95% confidence interval was performed. P-values < 0.05 were considered to be significantly different. Correlation between different parameters was analyzed using linear regression. P-values were calculated to determine whether slope was significantly non-zero and the strength of correlation was determined using R 2-value. All statistical analyses were performed using GraphPad Prism version 6.02.

Results

A primer set targeting O. volvulus cox1 was designed using LAMP Designer software (Fig. 1a, b). LAMP assays were performed on a dilution series of synthetic DNA containing the target sequence. Since there is a close sequence homology with other helminth parasites (Fig. 1a), assays were also performed on dilution series of synthetic DNA containing the heterologous sequence from Wuchereria bancrofti, Loa loa and Brugia malayi in order to determine the specificity of the primer set (Fig. 1c). The region heterologous to the O. volvulus region targeted by the assay (i.e. from F3 to B3 primer) was 87.0, 86.7 and 86.2% identical to sequences from W. bancrofti, L. loa and B. malayi, respectively. When the O. volvulus target sequence was used as a template, a clear amplification was observed, with concentration-dependent time to reach threshold fluorescence signal, whereas no amplification was observed within the time interval examined (45 min) when the same amount of heterologous DNA from W. bancrofti, L. loa or B. malayi was used.
Fig. 1

Design of a LAMP assay targeting O. volvulus cox1. a Alignment of partial gene sequences of cytochrome c oxidase subunit 1 from O. volvulus, W. bancrofti, L. loa, B. malayi and O. ochengi. b Primer set targeting O. volvulus cox1. c Species-specific LAMP assay targeting O. volvulus cox1. c Dilution series of gBlocks containing the cox1 fragment of O. volvulus, W. bancrofti, L. loa and B. malayi were used as template in the LAMP assay using real-time fluorescent dye detection. All samples were analyzed in duplicate. Dilution indicated with an asterisk had detectable signal in only one of both duplicates

Specificity of the assay was further investigated by examining the potential of the primer set to amplify the heterologous region of O. ochengi. Similarity between the O. volvulus cox1 and O. ochengi cox1 is very high, with only 10 nucleotide differences (i.e. 97.5% identity) over the entire sequence targeted by the assay (Fig. 1a). Consequently, both synthetic DNA fragments containing the respective target sequences are amplified with a similar efficiency and a same time to LAMP as a result (Fig. 2a). The few nucleotides difference does however result in a statistically different melting point (T m). Mean melt temperatures of 84.14 ± 0.03 and 83.73 ± 0.03 °C for O. volvulus cox1 and O. ochengi cox1, respectively (t (18) = 22.56, P < 0.0001, Fig. 2b), were determined across 10 reactions. Melting curves obtained on both DNA fragments were largely overlapping (Fig. 2c).
Fig. 2

O. volvulus cox1 assay discriminates between O. volvulus and O. ochengi. a Dilution series of gBlocks containing the cox1 fragment of O. volvulus and O. ochengi were used as template in the O. volvulus cox1 LAMP assay using real-time fluorescent dye detection. b Melting point determination of the amplicons generated from different dilutions of O. volvulus and O. ochengi template. c Melting curves of the amplicons generated from O. volvulus and O. ochengi template

To demonstrate the applicability of the O. volvulus cox1 LAMP assay to determine active O. volvulus infection in individuals living in endemic areas, skin biopsy samples were collected in the Ashanti Region, an onchocerciasis endemic region in Ghana. A total of 150 individuals, of which 99 had obvious nodules and 51 had no signs of onchocerciasis, were included in this study. Of the 99 nodule-positive individuals, only 10 were found to contain microfilariae upon microscopic examination. Total genomic DNA was isolated from these samples. From the 150 gDNA samples, 4 were excluded as they did not meet the acceptance criteria (see Methods). The 146 analysed extracts were tested for the presence of O. volvulus DNA using both qPCR and LAMP (Fig. 3a and Table 2). While only 9 individuals were found to be test-positive by microscopy, 17 were positive by qPCR and 15 by LAMP. This observation confirms the superior sensitivity of molecular detection over microscopic examination. These data also indicate a sensitivity of LAMP of 88.2% compared to qPCR (Table 3). The 2 samples negative in LAMP but positive in qPCR had Cq values of 35 and above, indicating they contained extremely low amounts of O. volvulus DNA. One sample that was found to be negative in qPCR was positive in LAMP, corresponding to a specificity of 99.2% as compared to qPCR. Also, a clear correlation could be observed between Cq values obtained during qPCR and the Time to LAMP obtained in the LAMP assay (R 2 = 0.555, P < 0.001).
Fig. 3

Comparison of results obtained by LAMP, O-150 qPCR and microscopic detection of microfilariae in skin snips. Comparison of results obtained by O. volvulus cox1 LAMP and O-150 qPCR for 146 subjects. Samples that were positive in microscopic examination are indicated in blue (n = 9). For each quadrant the total number of samples is indicated, as well as the number of microscopy positive samples in parentheses

Table 2

Cross tabulation of results obtained by qPCR, LAMP, microscopic detection of micro-filariae (mf) in skin snips, and nodule palpation for 146 individuals in the Adansi South District, Ghana

 

Nodule-positive

Nodule-negative

 

mf-positive

mf-negative

mf-positive

mf-negative

Totals

qPCR-positive

8

5

0

4

17

qPCR-negative

1

81

0

47

129

LAMP-positive

8

4

0

4

16

LAMP-negative

1

82

0

47

130

Totals

9

86

0

51

146

Abbreviation: mf microfilariae

Table 3

Determination of sensitivity and specificity of LAMP as compared to qPCR

 

qPCR-positive

qPCR-negative

 

LAMP-positive

15

1

PPV 93.8%

LAMP-negative

2

128

NPV 98.5%

 

Sensitivity: 88.2%

Specificity: 99.2%

 

Discussion

This work reports the development of a LAMP method for detection of O. volvulus DNA and its use in field collected skin biopsies from an onchocerciasis endemic region in Ghana. Currently, diagnosis of infection with O. volvulus is predominantly based on nodule palpation and microscopic detection of microfilariae in superficial skin biopsies [12]. The latter test is particularly useful for detection of active infection, but consequently suffers from insufficient sensitivity in an MDA era where the load of living microfilariae in the skin is dramatically reduced [37, 38]. Previous studies already demonstrated that the detection of O. volvulus DNA using PCR in such skin biopsies has a higher sensitivity than the classical microscopy approach [8]. Sensitivity was further improved by development of a probe-based qPCR assay [11]. qPCR also has the advantage that it is relatively fast and is less prone to contamination.

Results presented here demonstrate that similar sensitivities can be achieved with the O. volvulus cox1 LAMP assay. Only those samples containing very low levels of O. volvulus DNA (Cq values in qPCR > 35) were found to have a negative result in LAMP. Importantly, samples that were found to be positive upon microscopic examination were confirmed to be positive using qPCR and LAMP in eight out of nine cases. Although the O-150 qPCR assay has the advantage of targeting a repeat sequence that is present multiple times in the O. volvulus genome, the cox1 LAMP assay has a comparable clinical sensitivity of 88.2%. A likely explanation for this high sensitivity is the fact that the cox1 gene is located in the mitochondrial genome, while O-150 is located in the nuclear genome [39, 40]. Since every cell contains hundreds of mitochondrial DNA copies, it makes mitochondrial encoded sequences ideal targets for molecular detection requiring high sensitivity, as is the case for O. volvulus detection in skin biopsies [41]. For this reason, the cox1 gene has already been used as a target for other molecular assays to detect the presence of the jellyfish Cyanea nozakii in seawater samples or the presence of the olive tree pest Bactrocera oleae in the guts of arthropods [42, 43]. It will be of interest for future work to study whether a correlation exists between number of mf as determined by microscopy and time to LAMP. Sample collections from infected, but untreated patients will be essential for this as these samples should display a broader range of microfilaremia required to properly assess such correlation.

The LAMP assay presented here is also shown to be highly specific for Onchocerca species as no amplification could be observed when the heterologous DNA from W. bancrofti, L. loa and B. malayi were used as template in the reaction. However, the assay also detects O. ochengi, but with a slight difference in T m of the amplicons produced. As there is a large overlap in the melting curves obtained for both species, T m determination will be able to distinguish both species in case samples contain only DNA from one of both species but not in cases were both are present in one and the same sample. This cross-reactivity with O. ochengi DNA is not expected to pose an issue when used to analyze skin biopsies from humans as this species is typically present in cattle and not in humans [44]. As a consequence of this cross-reactivity this assay might not be ideally suited for specific detection of O. volvulus in Simulium blackfly vectors where it may be used to assess changes in parasite prevalence during or after MDA programs [4549].

The main advantages of isothermal amplification methods, such as LAMP, over PCR-based detection techniques, are the speed with which the assays can be completed, and the simple and relatively inexpensive equipment required [26, 50]. The O. volvulus cox1 LAMP assay we developed here reaches threshold fluorescence after just 10 min in cases of high target concentration and can take up to 30 min for low concentration samples. This characteristic, together with the availability of inexpensive reagents and the possibility to use a portable real time machine for monitoring the LAMP amplification, is of great importance for its use for point of care nucleic acid based diagnosis [51].

One major challenge of the analysis of O. volvulus DNA skin biopsies remains its invasive nature and the requirement of extraction techniques to isolate the parasitic DNA from this tissue sample [12]. Several efforts have been undertaken to evaluate simple extraction methods that are compatible with LAMP, of which boiling in 5% Chelex buffer or in NaOH appear to be the most promising approaches [52, 53]. Interestingly, extraction and LAMP detection have been integrated in single devices for detection of e.g. Mycobacterium tuberculosis in sputum samples [54]. Whether isolation of O. volvulus DNA from skin biopsies also can be achieved with high efficiency using similar extraction methods, will need to be further investigated.

Conclusions

We have developed a sensitive and specific loop-mediated amplification method for detection of O. volvulus DNA in skin biopsies that is capable of providing results within 30 min.

Abbreviations

actb

Beta-actin

Cq: 

Quantification cycle

Ct: 

Threshold cycle

LAMP: 

Loop-mediated isothermal amplification

MDA: 

Mass drug administration

mf: 

Microfilariae

NATOG: 

N-acetyltyramine-O,β-glucuronide

qPCR: 

Quantitative real-time PCR

T m

Melting temperature

UNG: 

Uracil N-glycosylase

Declarations

Acknowledgements

We thank Janssen Biobank for logistic support; and Bieke van Dorst, Liesbeth Van Wesenbeeck and Hanne Meeuws for scientific discussions.

Funding

Not applicable.

Availability of data and materials

All data generated or analyzed during this study are included in the article.

Authors’ contributions

OL, AD, LBD and LJS designed the study setup. OL, MM and LBD performed the experimental work. OL and LJS performed the analysis of the data. LJS contributed to revising the manuscript critically for important intellectual content and gave final approval of the version. All authors read and approved the final manuscript.

Competing interests

OL and LJS are current employees of Janssen Pharmaceutica NV, a Johnson and Johnson Company and may own stock or stock options in that company.

Consent for publication

Not applicable.

Ethics approval and consent to participate

The field study in Ghana was approved by the Committee on Human Research, Publications and Ethics of the School of Medical Sciences of the Kwame Nkrumah University of Science and Technology, Kumasi, Ghana and study subjects signed an informed consent form.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Janssen Diagnostics, Janssen R&D
(2)
Kumasi Centre for Collaborative Research into Tropical medicine, Kwame Nkrumah University of Science and Technology
(3)
Faculty of Allied Health Sciences, Kwame Nkrumah University of Science and Technology

References

  1. Enk CD. Onchocerciasis - river blindness. Clin Dermatol. 2006;24:176–80.View ArticlePubMedGoogle Scholar
  2. Borup LH, Peters JS, Sartori CR. Onchocerciasis (river blindness). Cutis. 2003;72:297–302.PubMedGoogle Scholar
  3. World Health Organisation. Working to overcome the global impact of neglected tropical diseases. Geneva: WHO/HTM/NTD/2010.1; 2010.Google Scholar
  4. Diawara L, Traore MO, Badji A, Bissan Y, Doumbia K, Goita SF, et al. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis. 2009;3(7):e497.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Traore MO, Sarr MD, Badji A, Bissan Y, Diawara L, Doumbia K, et al. Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal. PLoS Negl Trop Dis. 2012;6(9):e1825.View ArticlePubMedPubMed CentralGoogle Scholar
  6. World Health Organisation. African Programme for Onchocerciasis Control: progress report, 2014-2015. Weekly epidemiological record/Health Section of the Secretariat of the League of Nations. 2015;90(49):661-674.Google Scholar
  7. Taylor HR, Munoz B, Keyvan-Larijani E, Greene BM. Reliability of detection of microfilariae in skin snips in the diagnosis of onchocerciasis. Am J Trop Med. 1989;41(4):467–71.Google Scholar
  8. Toe L, Boatin BA, Adjami A, Back C, Merriweather A, Unnasch TR. Detection of Onchocerca volvulus infection by O-150 polymerase chain reaction analysis of skin scratches. J Infect Dis. 1998;178(1):282–5.View ArticlePubMedGoogle Scholar
  9. Fink DL, Fahle GA, Fischer S, Fedorko DF, Nutman TB. Toward molecular parasitologic diagnosis: enhanced diagnostic sensitivity for filarial infections in mobile populations. J Clin Microbiol. 2011;49(1):42–7.View ArticlePubMedGoogle Scholar
  10. Boatin BA, Toe L, Alley ES, Nagelkerke NJ, Borsboom G, Habbema JD. Detection of Onchocerca volvulus infection in low prevalence areas: a comparison of three diagnostic methods. Parasitology. 2002;125(Pt 6):545–52.PubMedGoogle Scholar
  11. Lloyd MM, Gilbert R, Taha NT, Weil GJ, Meite A, Kouakou IM, Fischer PU. Conventional parasitology and DNA-based diagnostic methods for onchocerciasis elimination programmes. Acta Trop. 2015;146:114–8.View ArticlePubMedGoogle Scholar
  12. Vlaminck J, Fischer PU, Weil GJ. Diagnostic tools for onchocerciasis elimination programs. Trends Parasitol. 2015;31(11):571–82.View ArticlePubMedGoogle Scholar
  13. Lipner EM, Dembele N, Souleymane S, Alley WS, Prevots DR, Toe L, et al. Field applicability of a rapid-format anti-Ov-16 antibody test for the assessment of onchocerciasis control measures in regions of endemicity. J Infect Dis. 2006;194(2):216–21.View ArticlePubMedGoogle Scholar
  14. Weil GJ, Steel C, Liftis F, Li BW, Mearns G, Lobos E, Nutman TB. A rapid-format antibody card test for diagnosis of onchocerciasis. J Infect Dis. 2000;182(6):1796–9.View ArticlePubMedGoogle Scholar
  15. Steel C, Golden A, Stevens E, Yokobe L, Domingo GJ, de Los Santos T, Nutman TB. Rapid point-of-contact tool for mapping and integrated surveillance of Wuchereria bancrofti and Onchocerca volvulus infection. Clin Vaccine Immunol. 2015;22(8):896–901.Google Scholar
  16. Golden A, Steel C, Yokobe L, Jackson E, Barney R, Kubofcik J, et al. Extended result reading window in lateral flow tests detecting exposure to Onchocerca volvulus: a new technology to improve epidemiological surveillance tools. PLoS One. 2013;8(7):e69231.View ArticlePubMedPubMed CentralGoogle Scholar
  17. Lavebratt C, Dalhammar G, Adamafio NA, Nykanen-Dejerud U, Mingarini K, Ingemarsson K, et al. A simple dot blot assay adaptable for field use in the diagnosis of onchocerciasis: preparation of an adult worm antigen fraction which enhances sensitivity and specificity. Trans R Soc Trop Med Hyg. 1994;88(3):303–6.View ArticlePubMedGoogle Scholar
  18. Chandrashekar R, Ogunrinade AF, Weil GJ. Use of recombinant Onchocerca volvulus antigens for diagnosis and surveillance of human onchocerciasis. Trop Med Int Health. 1996;1(5):575–80.View ArticlePubMedGoogle Scholar
  19. Globisch D, Moreno AY, Hixon MS, Nunes AAK, Denery JR, Specht S, et al. Onchocerca volvulus-neurotransmitter tyramine is a biomarker for river blindness. Proc Natl Acad Sci U S A. 2013;110(11):4218–23.View ArticlePubMedPubMed CentralGoogle Scholar
  20. Denery JR, Nunes AA, Hixon MS, Dickerson TJ, Janda KD. Metabolomics-based discovery of diagnostic biomarkers for onchocerciasis. PLoS Negl Trop Dis. 2010;4(10):e834.Google Scholar
  21. Lagatie O, Njumbe Ediage E, Batsa Debrah L, Diels L, Nolten C, Vinken P, et al. Evaluation of the diagnostic potential of urinary N-Acetyltyramine-O, beta-glucuronide (NATOG) as diagnostic biomarker for Onchocerca volvulus infection. Parasit Vectors. 2016;9(1):302.Google Scholar
  22. Tritten L, O’Neill M, Nutting C, Wanji S, Njouendoui A, Fombad F, et al. Loa loa and Onchocerca ochengi miRNAs detected in host circulation. Mol Biochem Parasitol. 2014;198(1):14–7.View ArticlePubMedGoogle Scholar
  23. Tritten L, Burkman E, Moorhead A, Satti M, Geary J, Mackenzie C, Geary T. Detection of circulating parasite-derived microRNAs in filarial infections. PLoS Negl Trop Dis. 2014;8(7):e2971.View ArticlePubMedPubMed CentralGoogle Scholar
  24. Quintana JF, Makepeace BL, Babayan SA, Ivens A, Pfarr KM, Blaxter M, et al. Extracellular Onchocerca-derived small RNAs in host nodules and blood. Parasit Vectors. 2015;8:58.View ArticlePubMedPubMed CentralGoogle Scholar
  25. Zhao Y, Chen F, Li Q, Wang L, Fan C. Isothermal amplification of nucleic acids. Chem Rev. 2015;115(22):12491–545.View ArticlePubMedGoogle Scholar
  26. Notomi T, Mori Y, Tomita N, Kanda H. Loop-mediated isothermal amplification (LAMP): principle, features, and future prospects. J Microbiol. 2015;53(1):1–5.View ArticlePubMedGoogle Scholar
  27. Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000;28(12):E63.View ArticlePubMedPubMed CentralGoogle Scholar
  28. Poole CB, Tanner NA, Zhang Y, Evans Jr TC, Carlow CK. Diagnosis of brugian filariasis by loop-mediated isothermal amplification. PLoS Negl Trop Dis. 2012;6(12):e1948.View ArticlePubMedPubMed CentralGoogle Scholar
  29. Takagi H, Itoh M, Kasai S, Yahathugoda TC, Weerasooriya MV, Kimura E. Development of loop-mediated isothermal amplification method for detecting Wuchereria bancrofti DNA in human blood and vector mosquitoes. Parasitol Int. 2011;60(4):493–7.View ArticlePubMedGoogle Scholar
  30. Poole CB, Ettwiller L, Tanner NA, Evans Jr TC, Wanji S, Carlow CK. Genome filtering for New DNA biomarkers of Loa loa infection suitable for loop-mediated isothermal amplification. PLoS One. 2015;10(9):e0139286.Google Scholar
  31. Fernandez-Soto P, Mvoulouga PO, Akue JP, Aban JL, Santiago BV, Sanchez MC, Muro A. Development of a highly sensitive loop-mediated isothermal amplification (LAMP) method for the detection of Loa loa. PLoS One. 2014;9(4):e94664.View ArticlePubMedPubMed CentralGoogle Scholar
  32. Drame PM, Fink DL, Kamgno J, Herrick JA, Nutman TB. Loop-mediated isothermal amplification for rapid and semiquantitative detection of Loa loa infection. J Clin Microbiol. 2014;52(6):2071–7.View ArticlePubMedPubMed CentralGoogle Scholar
  33. Alhassan A, Makepeace BL, LaCourse EJ, Osei-Atweneboana MY, Carlow CK. A simple isothermal DNA amplification method to screen black flies for Onchocerca volvulus infection. PLoS One. 2014;9(10):e108927.View ArticlePubMedPubMed CentralGoogle Scholar
  34. Debrah AY, Specht S, Klarmann-Schulz U, Batsa L, Mand S, Marfo-Debrekyei Y, et al. Doxycycline leads to sterility and enhanced killing of female Onchocerca volvulus worms in an area with persistent microfilaridermia after repeated ivermectin treatment: a randomized, placebo-controlled, Double-Blind Trial. Clin Infect Dis. 2015;61(4):517–26.Google Scholar
  35. Golden A, Faulx D, Kalnoky M, Stevens E, Yokobe L, Peck R, et al. Analysis of age-dependent trends in Ov16 IgG4 seroprevalence to onchocerciasis. Parasit Vectors. 2016;9(1):338.View ArticlePubMedPubMed CentralGoogle Scholar
  36. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215(3):403–10.View ArticlePubMedGoogle Scholar
  37. Boussinesq M, Prod’hon J, Chippaux JP, Quillevere D. Long-term effect of a single dose of ivermectin on skin microfilarial density in an endemic onchocerciasis area of North Cameroon. Ann Soc Belg Med Trop. 1993;73(3):189–96.PubMedGoogle Scholar
  38. Bottomley C, Isham V, Vivas-Martinez S, Kuesel AC, Attah SK, Opoku NO, et al. Modelling neglected tropical diseases diagnostics: the sensitivity of skin snips for Onchocerca volvulus in near elimination and surveillance settings. Parasit Vectors. 2016;9(1):343.Google Scholar
  39. Ferri E, Barbuto M, Bain O, Galimberti A, Uni S, Guerrero R, et al. Integrated taxonomy: traditional approach and DNA barcoding for the identification of filarioid worms and related parasites (Nematoda). Front Zool. 2009;6:1.View ArticlePubMedPubMed CentralGoogle Scholar
  40. Lefoulon E, Bain O, Bourret J, Junker K, Guerrero R, Canizales I, et al. Shaking the tree: multi-locus sequence typing usurps current onchocercid (filarial nematode) phylogeny. PLoS Negl Trop Dis. 2015;9(11):e0004233.View ArticlePubMedPubMed CentralGoogle Scholar
  41. Robin ED, Wong R. Mitochondrial DNA molecules and virtual number of mitochondria per cell in mammalian cells. J Cell Physiol. 1988;136(3):507–13.View ArticlePubMedGoogle Scholar
  42. Liu Z, Dong Z, Liu D. Development of a rapid assay to detect the jellyfish Cyanea nozakii using a loop-mediated isothermal amplification method. Mitochondrial DNA A DNA Mapp Seq Anal. 2016;27(4):2318–22.PubMedGoogle Scholar
  43. Rejili M, Fernandes T, Dinis AM, Pereira JA, Baptista P, Santos SA, Lino-Neto T. A PCR-based diagnostic assay for detecting DNA of the olive fruit fly, Bactrocera oleae, in the gut of soil-living arthropods. Bull Entomol Res. 2016;106(5):695–9.View ArticlePubMedGoogle Scholar
  44. Bwangamoi O. Onchocerca ochengi new species, an intradermal parasite of cattle in East Africa. Bull Epizoot Dis Afr. 1969;17(3):321–35.PubMedGoogle Scholar
  45. Katholi CR, Toe L, Merriweather A, Unnasch TR. Determining the prevalence of Onchocerca volvulus infection in vector populations by polymerase chain reaction screening of pools of black flies. J Infect Dis. 1995;172(5):1414–7.View ArticlePubMedGoogle Scholar
  46. Rodriguez-Perez MA, Gopal H, Adeleke MA, De Luna-Santillana EJ, Gurrola-Reyes JN, Guo X. Detection of Onchocerca volvulus in Latin American black flies for pool screening PCR using high-throughput automated DNA isolation for transmission surveillance. Parasitol Res. 2013;112(11):3925–31.View ArticlePubMedGoogle Scholar
  47. Gopal H, Hassan HK, Rodriguez-Perez MA, Toe LD, Lustigman S, Unnasch TR. Oligonucleotide based magnetic bead capture of Onchocerca volvulus DNA for PCR pool screening of vector black flies. PLoS Negl Trop Dis. 2012;6(6):e1712.View ArticlePubMedPubMed CentralGoogle Scholar
  48. Guevara AG, Vieira JC, Lilley BG, Lopez A, Vieira N, Rumbea J, et al. Entomological evaluation by pool screen polymerase chain reaction of Onchocerca volvulus transmission in Ecuador following mass Mectizan distribution. Am J Trop Med. 2003;68(2):222–7.Google Scholar
  49. Rodriguez-Perez MA, Katholi CR, Hassan HK, Unnasch TR. Large-scale entomologic assessment of Onchocerca volvulus transmission by poolscreen PCR in Mexico. Am J Trop Med. 2006;74(6):1026–33.Google Scholar
  50. Zhang X, Lowe SB, Gooding JJ. Brief review of monitoring methods for loop-mediated isothermal amplification (LAMP). Biosens Bioelectron. 2014;61:491–9.View ArticlePubMedGoogle Scholar
  51. Seyrig G, Stedtfeld RD, Tourlousse DM, Ahmad F, Towery K, Cupples AM, et al. Selection of fluorescent DNA dyes for real-time LAMP with portable and simple optics. J Microbiol Methods. 2015;119:223–7.View ArticlePubMedGoogle Scholar
  52. Nagai S, Yamamoto K, Hata N, Itakura S. Study of DNA extraction methods for use in loop-mediated isothermal amplification detection of single resting cysts in the toxic dinoflagellates Alexandrium tamarense and A. catenella. Mar Genomics. 2012;7:51–6.View ArticlePubMedGoogle Scholar
  53. Sun Y, Zhao L, Zhao M, Zhu R, Deng J, Wang F, et al. Four DNA extraction methods used in loop-mediated isothermal amplification for rapid adenovirus detection. J Virol Methods. 2014;204:49–52.View ArticlePubMedGoogle Scholar
  54. Creecy A, Russ PK, Solinas F, Wright DW, Haselton FR. Tuberculosis biomarker extraction and isothermal amplification in an integrated diagnostic device. PLoS One. 2015;10(7):e0130260.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2016

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Advertisement